IL18 and inflammatory bowel disease: Research has confirmed that pro-inflammatory cytokines such as IL-1β, TNF-α, IL-18, along withsignaling molecules like MyD88 and NF-κB, play central roles in regulating inflammatory responses and have been established as core biomarkers in DSS-induced inflammatory bowel disease (IBD) models.